Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma
Meera Mohan, Anikó Szabó, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine E. Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N. Shah, Frits van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D’Souza, Carolina Schinke
Topics & Concepts
MedicineStem cellMultiple myelomaInternal medicineImmunologyOncologyChimeric antigen receptorGastroenterologyImmunotherapyImmune systemGeneticsBiologyCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsIntegrated Circuits and Semiconductor Failure Analysis